{
  "id": "clinical#screening_cues_28a634a9",
  "content": "school suspension or employment suspension), affecting the probability that the person may\nseek treatment.\n6C42 Disorders due to use of synthetic cannabinoids\nDisorders due to use of synthetic cannabinoids are characterized by the pattern and consequences\nof synthetic cannabinoid use. Synthetic cannabinoids are synthesized diverse chemical\ncompounds that are potent agonists for endogenous cannabinoid receptors. There are several\nhundred such compounds. The synthetic compound is typically sprayed onto a vehicle such as\ncannabis or tea leaves and then smoked. The effect of these compounds is distinctly different from\nsmoking naturally cultivated cannabis, in that the euphoric effects are typically accompanied\nor dominated by psychotic-like symptoms (e.g. paranoia, hallucinations and disorganized\nDisorders due to substance use or addictive behaviours | Substance classes\n444 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nbehaviour). Synthetic cannabinoid intoxication may therefore present more frequently with\npsychotic symptoms in addition to the more typical effects of cannabis. Synthetic cannabinoids\nalso have dependence-producing properties, and synthetic cannabinoid dependence and synthetic\ncannabinoid withdrawal are recognized. Synthetic cannabinoid-induced mental disorders also\noccur; in particular, synthetic cannabinoid-induced psychotic disorder is recognized. Much less",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Screening Cues school suspension or employment suspension), affecting the probability that the person may\nseek treatment.\n6C42 Disorders due to use of synthetic cannabinoids\nDisorders due to use of synthetic cannabinoids are characterized by the pattern and consequences\nof synthetic cannabinoid use. Synthetic cannabinoids are synthesized diverse chemical\ncompounds that are potent agonists for endogenous cannabinoid receptors. There are several\nhundred such compounds. The synthetic compound is typically sprayed onto a vehicle such as\ncannabis or tea leaves and then smoked. The effect of these compounds is distinctly different from\nsmoking naturally cultivated cannabis, in that the euphoric effects are typically accompanied\nor dominated by psychotic-like symptoms (e.g. paranoia, hallucinations and disorganized\nDisorders due to substance use or addictive behaviours | Substance classes\n444 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nbehaviour). Synthetic cannabinoid intoxication may therefore present more frequently with\npsychotic symptoms in addition to the more typical effects of cannabis. Synthetic cannabinoids\nalso have dependence-producing properties, and synthetic cannabinoid dependence and synthetic\ncannabinoid withdrawal are recognized. Synthetic cannabinoid-induced mental disorders also\noccur; in particular, synthetic cannabinoid-induced psychotic disorder is recognized. Much less School suspension or employment suspension), affecting the probability that the person may\nseek treatment. 6c42 disorders due to use of synthetic cannabinoids\ndisorders due to use of synthetic cannabinoids are characteri..."
}